RxDoctor Payments Data

Michael Flood, MD

Plastic Surgery · Lancaster, PANPI 1346247715

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Misonix Inc accounts for 64.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $16,820 and has fallen 82.7% since, to $2,917 in 2025. Among plastic surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,349in general payments, 2019–2025

Across 97 payments — averaging $560.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Misonix Inc$35K
  • Lifenet Health$8K
  • Bioventus LLC$7K
  • Smith+Nephew$3K
  • KCI USA, Inc.$735
  • Tactile Systems Technology Inc$214
  • plus $431 from 6 others

What the payments were for

  • Consulting fees$24,12044%
  • Speaking & faculty fees$22,17741%
  • Travel & lodging$5,31210%
  • Food & beverage$2,7405%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,349 in reported general payments places this provider in the 90th percentile of 196 plastic surgery providers in Pennsylvania.

See all plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$79,864
Medicare patients
112
Services billed
771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate13$87
Oxycodone Hcl16$34

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →